CYTENA

We at CYTENA strive to empower our customers to serve patients faster and better. To accelerate workflows and bring new insights into biotherapeutic drug development, we provide precise control of individual cells through automation and microtechnology. Our instruments offer automated isolation of single cells with assurance of clonality and selection based on cell morphology. We can isolate many common cell types including bacteria. Our high viability rates make our instruments compatible with cell line development, single cell analysis, and other downstream applications. Most of the top ten largest pharmaceutical companies have successfully integrated cytena instruments into their workflows to quickly...

Monoclonality,single cells,cell line development,single cell genomics,single cell analysis,mab,monoclonal antibody,single-cell printer,gene therapy,ngs,omics,microbiome,single cell dispensers,single cell imagers,single cell cloning,single cell printer,stem cell therapy,microbioreactors,liquid handlers,lab automation instruments,and microplate washers

Cytena operates in the Biotechnology research industry.

Cytena's revenue is 11m - 100m

Cytena has 51 - 200 employees.